Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Achilles Therapeutics Plc (ACHL)

Achilles Therapeutics Plc (ACHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Achilles Therapeutics Plc 245 HAMMERSMITH ROAD LONDON X0 W6 8PW GBR

www.achillestx.com Employees: 215 P: 44-0-20-8154-4600

Description:

Achilles Therapeutics plc is a clinical-stage biopharmaceutical company. It engages in developing precision T cell therapies to treat solid tumors. Achilles Therapeutics plc is based in LONDON.

Key Statistics

Overview:

Market Capitalization, $K 43,142
Enterprise Value, $K -88,398
Shares Outstanding, K 41,088
Annual Sales, $ 0 K
Annual Net Income, $ -69,670 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -16,380 K
EBIT, $ -70,710 K
EBITDA, $ -66,000 K
60-Month Beta 1.35
% of Insider Shareholders 5.38%
% of Institutional Shareholders 56.38%
Float, K 38,877
% Float 94.62%
Short Volume Ratio 0.61

Growth:

1-Year Return 29.63%
3-Year Return -78.83%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.41 on 08/14/24
Next Earnings Date 11/18/24 [--]
Earnings Per Share ttm -1.59
EPS Growth vs. Prev Qtr -17.07%
EPS Growth vs. Prev Year -14.29%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ACHL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -51.69%
Return-on-Assets % -45.77%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.38
Book Value/Share 2.81
Interest Coverage -3.07
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar